Pfizer will halt its development of a weight-loss drug that was being closely watched by investors, in a significant blow to the US pharmaceutical group.
輝瑞(Pfizer)將停止開發其備受投資者關注的減肥藥，這對這家美國制藥集團來說是一個重大打擊。
您已閱讀5%（201字），剩余95%（3873字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。